Flagship ambitions in the lab: Olympus EVIS EXERA III raises the bar in endoscopy suites

With its EVIS EXERA III platform, Olympus targets hospitals and GI centers that want sharper imaging, streamlined workflows, and data integration from scope to server. The flagship system bundles video processors, light sources, and smart endoscopes into a single, networked backbone.

Edited by ad hoc news Flagship & Bestseller Desk. Reviewed before publication on 06/15/2026 at 4:42 PM ET. Details in the imprint.

In many US hospitals, the Olympus EVIS EXERA III endoscopy platform has quietly become a de facto flagship in gastroenterology and pulmonology suites, thanks to a combination of high-resolution imaging, flexible configuration, and tight integration with hospital IT systems. The official Olympus product page describes the platform as setting new standards in visualization, control, and workflow by linking scopes, processors, and electronic records into a unified system. Unlike stand-alone video processors of the past, EVIS EXERA III is sold as a modular ecosystem that includes colonoscopes, gastroscopes, bronchoscopes, light sources, image processors, and software designed to work together across multiple procedure rooms.

What the Olympus EVIS EXERA III platform actually delivers in the procedure room

At the technical core of EVIS EXERA III is a high-definition video processing unit that supports full 1080p output and Olympus proprietary imaging modes such as Narrow Band Imaging (NBI), which enhances the contrast of blood vessels and mucosal patterns by using specific blue and green light wavelengths. Olympus Europe explains that the system’s HD video chain and NBI function are designed to improve visualization of lesions in the GI tract and airways compared with conventional white light imaging. The platform can be paired with a wide range of EVIS EXERA III compatible endoscopes, including slim diagnostic colonoscopes for routine screening, therapeutic models with larger working channels for advanced interventions, and bronchoscopes optimized for access in the peripheral lung.

In daily use, the platform is built around a stack of components, typically including the CV-190 video processor, the CLV-190 light source, an image management hub, and the specific endoscope generation chosen by the hospital, all mounted in a standardized trolley for easy transport between rooms. According to an Olympus launch announcement for the EVIS EXERA III system in Europe, the platform’s design also emphasizes easier reprocessing and standardized cabling to shorten turnaround time between procedures and reduce the risk of setup errors. Image and video capture can be routed directly into hospital PACS or specialty endoscopy documentation systems, which is increasingly relevant in the US market as GI and pulmonary groups standardize quality metrics and auditing requirements across their facilities.

From a workflow perspective, the EVIS EXERA III platform is not just about the tower and scopes but about creating a consistent environment in which technicians can quickly prepare rooms, physicians can rely on familiar controls across different specialties, and administrators can track equipment utilization and maintenance. The same basic configuration can support upper GI, lower GI, ERCP, and bronchoscopy, which simplifies staff training and allows larger centers to consolidate purchasing around a single vendor. For facilities that are still transitioning from earlier Olympus systems, EVIS EXERA III also offers backwards compatibility with many existing endoscopes, helping spread capital expenditures over multiple budget cycles instead of forcing an all-at-once replacement.

Strategically, Olympus positions the EVIS EXERA III as a high-volume workhorse for hospitals and ambulatory surgery centers that perform large numbers of endoscopy and bronchoscopy procedures, even as newer platforms like EVIS X1 begin to appear at the very top of the portfolio. The system has been in the market long enough for procurement teams to compare real-world reliability and service costs with competing offerings, which keeps it relevant for buyers who value proven performance over first-generation technology. Olympus, whose medical business is listed in Tokyo under the ISIN JP3197800000, last traded on the TSE at JPY 2,231 on 06/13/2026, underscoring the importance of endoscopy platforms like EVIS EXERA III to its long-term revenue profile.

Olympus EVIS EXERA III in brief: the hard facts

• Product: Olympus EVIS EXERA III endoscopy platform
• Manufacturer: Olympus Corporation
• Category: Flagship endoscopy system for GI and respiratory procedures
• Launch date: Initially introduced in early 2010s, still widely installed
• MSRP / Price: Typically configured as a multi-component system; pricing depends on tower and scope mix and is usually negotiated for institutional buyers
• Availability: Available through Olympus medical distributors and direct sales in the US, Europe, and Asia-Pacific markets
• Target audience: Hospitals, university medical centers, and ambulatory surgery centers performing GI and respiratory endoscopy
• Key differentiator / USP: Integrated HD imaging with Narrow Band Imaging, broad scope compatibility, and workflow-focused design for multi-room endoscopy suites

This article was a.i.-assisted and editorially reviewed. Product information without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Trading involves risk up to and including the total loss of invested capital.